Wordt geladen...
How we treat cytomegalovirus in hematopoietic cell transplant recipients
Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell transplantation (HCT). Over the past decade, most centers have adopted preemptive antiviral treatment or prophylaxis strategies to prevent CMV disease. Both strategies are effective but also have shortcomings with...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2700312/ https://ncbi.nlm.nih.gov/pubmed/19299333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-10-143560 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|